UPMC Enterprises is proud to announce that two leaders, Matthias Kleinz, PhD, Executive Vice President of Translational Sciences, and Mani Mohindru, PhD, CEO of Novasenta, have been recognized by the Pittsburgh Business Times in their “20 People to Know in Health Care” list for 2024.
Matthias Kleinz, PhD – A Visionary in Translational Sciences
Dr. Matthias Kleinz, with his extensive experience and innovative approach, has been instrumental in advancing our translational sciences focus area. His work is pivotal in bridging the gap between scientific research and clinical application, ensuring that breakthroughs in the lab can make a real-world impact on patient care.
Read the full profile on Dr. Kleinz here: https://bizj.us/1qkht7
Mani Mohindru, PhD – Leading the Charge in Cancer Therapeutics
At the helm of Novasenta, a UPMC Enterprises portfolio company, Dr. Mani Mohindru is making strides in the field of cancer therapeutics. Her leadership and strategic direction are driving Novasenta’s mission to develop innovative therapies that can change the lives of cancer patients.
Read the full article on Dr. Mohindru here: https://bizj.us/1qki7q
We congratulate both Dr. Kleinz and Dr. Mohindru on this well-deserved recognition. Their contributions make a significant impact on the broader health care landscape. We look forward to their continued leadership and groundbreaking work in their respective fields.
